Britta Weigelt, PhD

About Me

I am a research scientist with expertise in  high-throughput transcriptomics and the genomics of breast and endometrial cancers. I have employed these techniques to study the biology and molecular classification of breast cancer subtypes, and to inform functional studies aiming to define the molecular markers of response to specific targeted therapies in breast and endometrial cancer cells.

Read more

My current research program focuses on the study of endometrial cancers, the most common gynecologic cancer in developed countries. Benefiting from the extensive tissue collections in the Department of Pathology and the state-of-the art facilities at Memorial Sloan Kettering Cancer Center, we are combining traditional pathological techniques with cutting-edge tools for genetic analyses and functional studies. Our aim is to identify biologically relevant subclasses of endometrial cancers and their driving molecular aberrations. The goal of our research is to define how these molecular changes can be exploited to inform us about the optimal therapy for specific patients with endometrial cancer.

In addition, in collaboration with Jorge Reis-Filho’s laboratory, we are characterizing the genetic alterations of rare types of breast cancer for the development of a molecular classification of breast cancers based on their potential therapeutic targets.

  • Clinical Expertise: Experimental Pathology; Genomics; Breast and Gynecologic Cancers
  • Languages Spoken: English
  • Education: PhD, The Netherlands Cancer Institute, University of Amsterdam (Amsterdam, The Netherlands)
  • Fellowships: Lawrence Berkeley National Laboratory (Berkeley, California); Cancer Research UK London Research Institute (London, UK)

New Patient Appointments

Making an appointment

Call 800-525-2225

See My Colleagues

Publications

Visit PubMed for a full listing of Britta Weigelt’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more